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Abstract 
In this study, the preparation, characterization and drug release behaviour of 
gentamicin (GM)-loaded poly(D,L-lactide-co-glycolide) (PLGA) microspheres are 
described. The microspheres were produced using a double emulsion solvent 
evaporation technique. All the microspheres preparation resulted in spherical shape and 
the mean diameter was 3 μm (for empty microspheres) and between 5 and 9 μm for 
microparticles loaded with GM. The encapsulation efficiency ranged from 3.4 to 90% 
depending on the formulation. Increasing the volume of the external aqueous phase, 
increased the encapsulation efficiency. Encapsulation also depended on the pH value of 
the internal aqueous phase, the highest value was achieved when maintained the internal 
aqueous phase at pH 6, where GM was more soluble. Moreover, increasing nominal 
GM loading yielded lower encapsulation efficiencies. The release profiles of GM from 
microparticles resulted in biphasic patterns. After an initial burst, a continuos drug 
release was observed for up to four weeks. Finally, the formulations with higher loading 
released the drug faster.  
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The need for improving actual treatments of microbial infections by intracellular 
pathogens, such as Brucella, encouraged us to study the physical targeting of antibiotics 
by drug delivery systems (Gamazo et al., 1999). Antibiotics are effective against 
Brucella in vitro, however, during infection the bacterium is localized intracellularly 
making the treatment difficult (Hall, 1990). The therapeutics requires the association of 
more than one antimicrobial for weeks (Ariza, 1999) and that often lead to poor patient 
compliance, contributing to low therapy efficiency (Solera et al., 1997). Particulate 
carriers such as biodegradable microspheres, may target the antibiotics to the 
intracellular sites where the bacterium is found, and as being in a sustained manner, 
would permit to reduce the number of doses and decrease drug toxicity (Gamazo et al., 
1999). 
In a previous work, Prior et al., (2000) found that GM loaded-microparticles 
prepared by spray-drying and using the uncapped Poly(D,L-lactide-co-glycolide) 
polymer (PLGA, RG 502H) showed a low burst and a continuous release profile. This 
property makes this formulation suitable as a possible therapy in brucellosis. 
Nevertheless, using spray-drying, a strong particle aggregation was observed making 
difficult its administration in mice. Therefore, the objective of this work was to prepare 
GM loaded microparticles by a double solvent evaporation method, in order to avoid 
particle aggregation, and to study GM in vitro release. 
Poly(D,L-lactide-co-glycolide) (PLGA 50:50) with free carboxyl end groups 
was purchased from Boehringer Ingelheim (Ingelheim, Germany; RG 502H, inherent 
viscosity of 0.2 dL/g). Polyvinyl alcohol (PVA) 115000 MW was supplied by BDH 
(Poole, England) and dichloromethane was provided by Prolabo (Fontenay, France). 
Freeze-dried GM sulphate was obtained from Sigma Chemical Co. (Madrid, Spain).  
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Microparticles were obtained by the double emulsion solvent evaporation 
technique (Blanco-Príeto et al., 1996). Briefly, different amounts of GM dissolved in 
0.2 mL of a PVA 0.5% aqueous solution (W1) and 0.2 g of PLGA dissolved in 5 mL of 
dichloromethane (O) were mixed by ultrasonication for 30 s under cooling to form a 
W1/O emulsion. This inner emulsion was added to 10 or 30 mL of an aqueous PVA 1% 
solution (W2), and homogenized using an Ultraturax®. The resulting (W1/O/W2) 
solution was stirred for at least three hours under room temperature to allow solvent 
evaporation and microspheres formation. After preparation, the microspheres were 
isolated by centrifugation 7000g for 10 min, washed with distilled water and freeze-
dried.  
Ten batches of microspheres were prepared which characteristics are shown in 
tables 1 and 2. For batches E-J, the inner water phase was maintained at pH 6, where 
GM is more soluble. Microparticles diameter was measured by laser diffractometry, 
using a Matersizer S (Malvern Instruments, Worcestershire, U.K.).  
Encapsulated GM was determined by dissolving the loaded microspheres in       
1 mL of dichloromethane and the drug was extracted with 2 mL of phosphate buffer   
pH 6. The GM content in the PLGA microspheres was determined fluorometrically 
using a Cytofluor 2300/2350 (Millipore). Fluorescence was measured after derivation 
with o-phthaldehyde with excitation and emission wavelengths of 360 nm and 460 nm, 
respectively (Benson and Hare, 1975).  
In vitro drug release profiles were obtained by incubating the microspheres in 
1.5 mL of phosphate buffer saline (PBS) pH 7.4 under continuous shaking and at 37 ºC. 
At regular intervals, the vials were centrifuged at 986g for 10 min and GM was 
quantified in the supernatant, as described above. 
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All the microspheres resulted in spherical shape and the mean diameter was 3 
μm (for empty microspheres) and between 5 and 9 μm for microparticles loaded with 
GM (Tables 1 and 2). The resuspension characteristics after lyophilization were good 
and the particles showed no aggregation. The effect of the volume of W2 and the 
amount of GM introduced in W1 in the encapsulation efficiency (EE) is shown in tables 
1 and 2. Increasing the volume of W2 from 10 to 30 mL of PVA 1% also increased the 
EE. Jeffery et al., (1993) also observed an increase in the EE of ovalbumin into PLGA 
microspheres when the volume of the external aqueous phase was risen. This effect 
could be attributed to the increase of the particle size which enable more drug to be 
incorporated into the microspheres. On the other hand, increasing the amount of GM in 
the initial emulsion to a value of 50 mg reduced the EE as described also by Prior et al., 
(2000). Finally, the highest EE was achieved when maintained W1 at pH 6, where GM 
was more soluble (Table 2). For formulation J, an encapsulation rate of 54 μg of 
GM/mg of polymer was obtained when 50 mg of GM were dissolved in the inner 
aqueous phase of the emulsion. 
The in vitro release of GM from microparticles is shown in figure 1, indicating 
that microparticles with a higher loading (batches G and J) released GM faster. This 
results agree with the observations by Sah et al., (1994). For all the formulations, after 
an initial burst, a continuous GM release was observed for up to 4 weeks (figure 1). 
In this work size, loading, resuspension characteristics after lyophilization and 
GM released of PLGA microspheres prepared by a (W1/O/W2) solvent evaporation 
method were investigated. It was found that maintaining the inner aqueous phase at    
pH 6 improved GM encapsulation and the microparticles showed no aggregation. 
Furthermore, a continuos GM release was observed for up to four weeks. The obtained 
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microspheres could be useful as a prolonged drug delivery system for brucellosis 
treatment. Accordingly, the next step of this work will be to study the therapeutic effect 
of this particles in vivo. 
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Figure Legend 
Figure 1. Cumulative in vitro release profiles of GM from PLGA microparticles, in 
PBS. 
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Table 1. Microspheres characteristics. W1: PVA 1% 
Batch W2 (mL) Size (μm) mg GM (W1) EE (%) μg GM/mg 
polymer 
A 30 6.0 5 8.7 2.12 
B 30 6.6 10 9.2 4.36 
C 10 5.4 5 7.1 1.72 
D 10 5.7 10 3.4 1.61 
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Table 2. Microspheres characteristics. W1: PVA 1% pH 6 
Batch W2 (mL) Size (μm) mg GM (W1) EE (%) μg GM/mg 
polymer 
E 10 5.6 5 66 12 
F 10 5.8 10 24 16 
G 10 6.0 50 11.5 23 
H 30 7.1 5 90 22 
I 30 7.4 10 54 26 
J 30 9.0 50 27 54 
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Figure 1. 
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